159 related articles for article (PubMed ID: 2681508)
1. Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
Ytre-Arne K; Nordøy A
J Intern Med; 1989 Nov; 226(5):285-90. PubMed ID: 2681508
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
[TBL] [Abstract][Full Text] [Related]
4. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin (MK 733): an effective treatment for hypercholesterolemia.
Lintott CJ; Scott RS; Nye ER; Robertson MC; Sutherland WH
Aust N Z J Med; 1989 Aug; 19(4):317-20. PubMed ID: 2675812
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.
Mölgaard J; Lundh BL; von Schenck H; Olsson AG
Atherosclerosis; 1991 Dec; 91 Suppl():S21-8. PubMed ID: 1789813
[TBL] [Abstract][Full Text] [Related]
7. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
Deslypere JP
Acta Cardiol; 1989; 44(5):379-88. PubMed ID: 2690545
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with simvastatin compared with cholestyramine.
Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ
Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of simvastatin (alone or in association with cholestyramine). A 1-year study in 66 patients with type II hyperlipoproteinaemia.
Emmerich J; Aubert I; Bauduceau B; Dachet C; Chanu B; Erlich D; Gautier D; Jacotot B; Rouffy J
Eur Heart J; 1990 Feb; 11(2):149-55. PubMed ID: 2178931
[TBL] [Abstract][Full Text] [Related]
11. HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
Maher VM; Thompson GR
Q J Med; 1990 Feb; 74(274):165-75. PubMed ID: 2111917
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
13. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Mol MJ; Stuyt PM; Stalenhoef AF
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
[TBL] [Abstract][Full Text] [Related]
15. The use of simvastatin, an HMG CoA reductase inhibitor, in older patients with hypercholesterolemia and atherosclerosis.
Bach LA; Cooper ME; O'Brien RC; Jerums G
J Am Geriatr Soc; 1990 Jan; 38(1):10-4. PubMed ID: 2404052
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
[TBL] [Abstract][Full Text] [Related]
17. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
Maher VM; Gallagher JJ; Thompson GR; Myant NB
Atherosclerosis; 1991 Nov; 91(1-2):73-6. PubMed ID: 1811555
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
19. Treating hypercholesterolaemia with HMG CoA reductase inhibitors: a direct comparison of simvastatin and pravastatin.
Lintott CJ; Scott RS; Sutherland WH; Bremer J
Aust N Z J Med; 1993 Aug; 23(4):381-6. PubMed ID: 8240151
[TBL] [Abstract][Full Text] [Related]
20. Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.
Simons LA; Sullivan D; Simons J; Celermajer DS
Atherosclerosis; 1998 Mar; 137(1):197-203. PubMed ID: 9568752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]